Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species.
Candida albicans
fluconazole tolerance
pitavastatin calcium
reactive oxygen species
ubiquinone biosynthesis
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
29 May 2024
29 May 2024
Historique:
received:
27
03
2024
revised:
28
05
2024
accepted:
28
05
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
27
6
2024
Statut:
epublish
Résumé
Fluconazole (FLC) is extensively employed for the prophylaxis and treatment of invasive fungal infections (IFIs). However, the fungistatic nature of FLC renders pathogenic fungi capable of developing tolerance towards it. Consequently, converting FLC into a fungicidal agent using adjuvants assumes significance to circumvent FLC resistance and the perpetuation of fungal infections. This drug repurposing study has successfully identified pitavastatin calcium (PIT) as a promising adjuvant for enhancing the fungicidal activity of FLC from a comprehensive library of 2372 FDA-approved drugs. PIT could render FLC fungicidal even at concentrations as low as 1 μM. The median lethal dose (LD
Identifiants
pubmed: 38929106
pii: antiox13060667
doi: 10.3390/antiox13060667
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Key Research and Development Program of China
ID : 2022YFC2303004
Organisme : National Key Research and Development Program of China
ID : 2021YFC2300404
Organisme : National Natural Science Foundation of China
ID : 82020108032
Organisme : Innovation Program of Shanghai Municipal Education Commission
ID : 202101070007-E00094